The impact of pandemic influenza A H1N1 2009 on Australian lung transplant recipients

American Journal of Transplantation

Volumn 11, Issue 3, 2011, Pages 568-574

  Ng, Benjamin J H ^a   Glanville, A R ^b   Snell, G ^c   Musk, M ^d   Holmes, M ^e   Chambers, D C ^a   Hopkins, P M A ^a  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c ALFRED HOSPITAL   (Australia)

^d ROYAL PERTH HOSPITAL   (Australia)

^e ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Bronchiolitis obliterans syndrome; H1N1 subtype; Influenza A; Lung transplantation; Outcomes; Pandemic influenza

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CORTICOSTEROID; MYCOPHENOLIC ACID; OSELTAMIVIR; PREDNISOLONE; TACROLIMUS;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; AUSTRALIA; BRONCHIOLITIS OBLITERANS; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DATA BASE; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFLUENZA A (H1N1); LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; MORBIDITY; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PANDEMIC INFLUENZA; PRIORITY JOURNAL; UPPER RESPIRATORY TRACT INFECTION;

EID: 79951987053     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03422.x     Document Type: Article

References (30)

1. Matar L, McAdams H, Palmer S. Respiratory viral infections in lung transplant recipients: Radiologic findings with clinical correlation. Radiology 1999; 213: 735-742.
2. Vilchez RA, McCurry K, Dauber J et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002; 2: 287-291. (Pubitemid 36330248)
3. Glanville A, Scott A, Morton J et al. Intravenous ribavirin is a safe and cost effective treatment for respiratory syncytial virus infection after lung transplantation. J Heart Lung Transplant 2005; 24: 2114-2119. (Pubitemid 41814734)
4. Hopkins P, McNeil K, Kermeen F et al. Human metapneumo virus in lung transplant recipients and comparison to respiratory syncytial virus. Am J Respir Crit Care Med 2008; 178: 876-881.
5. Kumar D, Humar A. Pandemic influenza and its implications for transplantation. Am J Transplant 2006; 6: 1512-1517. (Pubitemid 43945790)
6. Kotsimbos T, Waterer G, Jenkins C et al. Thoracic Society of Australia and New Zealand H1N1 Influenza 09 Task Force. Influenza A/H1N1-09: Australia and New Zealand's winter of discontent. Am J Respir Crit Care Med 2010; 181: 300-306.
7. Australian Government Department of Health and Ageing. Australian Influenza Surveillance report No. 26 [accessed November 22, 2009]. Available from: http: //www.health.gov.au/internet/healthemergency/publishing.nsf/Content/ ozflu2009.htm/$File/ozflu-no26-2009
8. Davies A, Jones D, Bailey Met al. Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome. JAMA 2009; 302: 1888-1895.
9. Kumar D, Michaels MG, Morris MI et al. American Society of Transplantation H1N1 Collaborative Study Group. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: A multicentre cohort study. Lancet Infect Dis 2010; 10: 521-526.
10. Fox BD, Raviv Y, Rozengarten D, Rusanov V, Bakal I, Kramer MR. Pandemic influenza (H1N1): Impact on lung transplant recipients and candidates. J Heart Lung Transplant 2010; 29: 1034-1038.
11. Khalifah AP, Hachem RR, Chakinala MM et al. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 2004; 1702: 181-187. (Pubitemid 38925165)
12. Kumar D, Erdman D, Keshavjee S et al. Clinical impact of community acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant 2005; 8: 2031-2036. (Pubitemid 41039882)
13. Estenne M, Maurer JR, Boehler A et al. Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297-310.
14. Lennette EH, Balows A, Hausler WJ, Shadomy HJ. Manual of clinical microbiology, 4th Ed. Washington, DC: American Society of Microbiology, 1995.
15. Whiley DM, Bialasiewicz S, Bletchly C et al. Detection of novel influenza A (H1N1) virus by real-time RT-PCR. J Clin Virol 2009; 45: 203-204.
16. Australian Government Department of Health and Ageing. Australian Health Management Plan for Pandemic Influenza. 2008. Available from: http://www.flupandemic.gov.au/internet/panflu/publishing.nsf/Content/ 8435EDE93CB6FCB8CA2573D700128ACA/$File/Pandemic%20FINAL%20webready.pdf
17. Seville MT, Blair JE, Vikram HR, Kusne S. 2009 H1N1 Influenza in hospitalized transplant recipients. Transplantation 2010; 90: 57-574.
18. Wendt C. Community respiratory viruses: Organ transplant recipients. Am J Med 1997; 102: 31-36.
19. Nguyen-Van-Tam JS, Openshaw PJ, Hashim A et al. Influenza Clinical Information Network (FLU-CIN). Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009). Thorax 2010; 65: 645-651.
20. Hopkins PM, Plit ML, Carter IW, Chhajed PN, Malouf MA, Glanville AR. Indirect fluorescent antibody testing of nasopharyngeal swabs for influenza diagnosis in lung transplant recipients. J Heart Lung Transplant 2003; 22: 161-168. (Pubitemid 36173673)
21. Mollura DJ, Asnis DS, Crupi RS et al. Imaging findings in a fatal case of pandemic swine-origin influenza A (H1N1). Am J Roentgenol 2009; 193: 1500-1503.
22. Ellis J, Iturriza M, Allen R et al. Evaluation of four real-time PCR assays for detection of influenza A (H1N1)v viruses. Euro Surveill 2009; 14: pii 19230.
23. Gimeno C, Navarro D. Real-time reverse-transcription PCR in the diagnosis of influenza A (H1N1)v in intensive care unit adult patients. Crit Care 2009; 13: 428.
24. Kumar D, Morris M, Kotton C et al. AST Infectious Diseases Community of Practice and Transplant Infectious Diseases Section of TTS. Guidance on novel influenza A/H1N1 in solid-organ transplant recipients. Am Journal of Transplant 2010; 10: 18-25.
25. Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: Risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004; 39: 1300-1306. (Pubitemid 39458515)
26. Jartti T, Lehtinen P, Vuorinen T, Koskenvuo M, Ruuskanen O. Persistence of rhinovirus and enterovirus RNA after acute respiratory illness in children. J Med Virol 2004; 72: 695-699. (Pubitemid 38296085)
27. Bonville CA, Mehta PA, Krilov LR, Rosenberg HF, Domachowske JB. Epithelial cells infected with respiratory syncytial virus are resistant to the anti-inflammatory effects of hydrocortisone. Cell Immunol 2001; 213: 134-10.
28. Harms PW, Schmidt LA, Smith LB et al. Autopsy findings in eight patients with fatal H1N1 influenza. Am J Clin Pathol 2010; 134: 27-35.
29. Garantziotis S, Howell DN, McAdams HP, Davis RD, Henshaw NG, Palmer SM. Influenza pneumonia in lung transplant recipients: Clinical features and association with bronchiolitis obliterans syndrome. Chest 2001; 119: 1277-1280. (Pubitemid 32679462)
30. Faul JL, Akindipe OA, Berry GJ, Theodore J. Influenza pneumonia in a paediatric lung transplant recipient. Transpl Int 2000; 13: 79-81. (Pubitemid 30417388)